Advertisement

Neurological Manifestations of Systemic Chronic Inflammatory Disease

  • Andrew R. Pachner
Chapter
  • 1k Downloads

Abstract

Both chronic systemic inflammatory diseases and neurological diseases occur frequently so an occurrence of both in a single patient may be due to chance alone. However, there are a number of systemic inflammatory diseases which commonly involve the nervous system. Selected ones which are most likely to be seen by a practicing neurologist in the community are briefly summarized below. A more thorough review of neurological involvement in patients with rheumatic disease was recently published by Sofat et al. [1]. Rheumatic disease, or rheumatism, is a term used to denote the field of medicine of connective tissue and joint disorders, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), vasculitides, and other diseases in which inflammation is prominent and a precise etiology has not been defined.

Keywords

Systemic Lupus Erythematosus Giant Cell Arteritis Polymyalgia Rheumatica Reversible Cerebral Vasoconstriction Syndrome Cerebral Venous Sinus Thrombosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Sofat N, Malik O, Higgens CS. Neurological involvement in patients with rheumatic disease. QJM. 2006;99(2):69–79.PubMedCrossRefGoogle Scholar
  2. 2.
    Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16(1):2–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore). 1976;55(4):323–39.CrossRefGoogle Scholar
  4. 4.
    Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002;58(8):|1214–20.PubMedGoogle Scholar
  5. 5.
    Kaul M, Erkan D, Sammaritano L, Lockshin MD. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2007;66(7):927–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Levine SR, Brey RL, Tilley BC, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004;291(5):576–84.PubMedCrossRefGoogle Scholar
  7. 7.
    Alexander EL, Provost TT, Stevens MB, Alexander GE. Neurologic complications of primary Sjogren’s syndrome. Medicine (Baltimore). 1982;61(4):247–57.Google Scholar
  8. 8.
    Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore). 2004;83(5):280–91.CrossRefGoogle Scholar
  9. 9.
    Rossi CM, Di Comite G. The clinical spectrum of the neurological involvement in vasculitides. J Neurol Sci. 2009;285(1–2):13–21.PubMedCrossRefGoogle Scholar
  10. 10.
    Kissel JT, Slivka AP, Warmolts JR, Mendell JR. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol. 1985;18(2):251–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Birnbaum J, Hellmann DB. Primary angiitis of the central nervous system. Arch Neurol. 2009;66(6):704–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Neel A, Pagnoux C. Primary angiitis of the central nervous system. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S95–107.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Andrew R. Pachner
    • 1
  1. 1.Department of Neurology and Neuroscience New Jersey Medical SchoolUniversity of Medicine and Dentistry of New JerseyNewarkUSA

Personalised recommendations